Autres langues Instadose Pharma Corp.

Actions

INSD

US45783B1035

Marché Fermé - OTC Markets Autres places de cotation 21:34:47 29/12/2023			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	-.--%		-.--%	-.--%

2023	TetraPharma Royalty Corp. a acquis TetraPharma (Canada) Ltd. auprès d'Instadose Pharma Corp. (OTCPK:INSD).	CI
2022	Instadose Pharma Corp. annonce des changements au conseil d'administration	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

TetraPharma Royalty Corp. acquired TetraPharma Ltd. from Instadose Pharma Corp..	19/09/23
An unknown buyer entered into an agreement to acquire TetraPharma Ltd. from Instadose Pharma Corp. for $0.0001 million.	07/07/23
INSTADOSE PHARMA CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	07/11/22
Instadose Pharma Corp. Announces Board Changes	07/11/22
Instadose Pharma Corp. Announces Resignation of Alex Wylie as Chief Financial Officer	07/11/22
Instadose Pharma Corp. Announces CEO Changes	07/11/22
INSTADOSE PHARMA CORP. : Non-Reliance on Previous Financials, Audits or Interim Review, Financial Statements and Exhibits (form 8-K)	04/11/22
INSTADOSE PHARMA CORP. : Financial Statements and Exhibits (form 8-K)	28/09/22
INSTADOSE PHARMA CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	09/05/22
Instadose Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	09/05/22
Instadose Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	09/05/22
INSTADOSE PHARMA CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	15/03/22
Instadose Pharma Corp. Reports Earnings Results for the Full Year Ended November 30, 2021	15/03/22
INSTADOSE PHARMA CORP. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	23/02/22
Investor Notice: Feb 28th Deadline for certain Investors in Instadose Pharma Corp. shares announced by Shareholders Foundation	16/02/22
INSTADOSE PHARMA CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	19/01/22
Instadose US Announces Management Transition	14/01/22
Instadose US Announces Management Transition	14/01/22
Instadose Pharma Corp. Announces Management Transition	14/01/22
INSTADOSE PHARMA CORP. : Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Other Events (form 8-K)	07/01/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Instadose Pharma Corp.

Actions

INSD

US45783B1035

Autres langues

Filtres